We found that both rhNRG1and CAFs promoted cell proliferation and osimertinib resistance, interestingly, when NRG1 neutralizing antibody was added to CAF-CM, CAF's effect on lung cancer cell proliferation was abrogated (Figure 5A). Here, NRG1 is linked to lung cancer.